 Connection
Angela Thompson to Humans
This is a "connection" page, showing publications Angela Thompson has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.053 |
|
|
|
-
Marrs JC, Thompson AM. Antihypertensive Therapy in Females: A Clinical Review Across the Lifespan. Pharmacotherapy. 2016 06; 36(6):638-51.
Score: 0.015
-
Thompson AM, Trujillo JM. Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes. Ann Pharmacother. 2015 Mar; 49(3):351-9.
Score: 0.013
-
Bhat S, Kroehl M, Maniga B, Navarro A, Thompson AM, Lam HM, Trinkley KE. Patient Outreaches for Clinical Pharmacy Services: A Population Health Management Program Assessment. J Pharm Pract. 2021 Feb; 34(1):58-63.
Score: 0.005
-
Tuchscherer RM, Thompson AM, Trujillo JM. Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 Diabetes. Ann Pharmacother. 2018 12; 52(12):1224-1232.
Score: 0.004
-
Blackmer AB, Thompson AM, Jeffres MN, Glode AE, Thompson M, Mahyari N. Clinical pharmacy academic career transitions: Viewpoints from the field. Curr Pharm Teach Learn. 2018 02; 10(2):121-122.
Score: 0.004
-
Blackmer AB, Thompson AM, Jeffres MN, Glode AE, Mahyari N, Thompson M. Clinical pharmacy academic career transitions: Viewpoints from the fieldPart 1: Understanding feedback, evaluation, and advancement. Curr Pharm Teach Learn. 2018 02; 10(2):123-127.
Score: 0.004
-
Jeffres MN, Blackmer AB, Thompson AM, Glode AE, Mahyari N, Thompson M. Clinical pharmacy academic career transitions: Viewpoints from the field part 3: Learning when and how to say yes. Curr Pharm Teach Learn. 2018 02; 10(2):133-136.
Score: 0.004
-
Tsai T, Kroehl ME, Smith SM, Thompson AM, Dai IY, Trinkley KE. Efficacy and safety of twice- vs once-daily dosing of lisinopril for hypertension. J Clin Hypertens (Greenwich). 2017 Sep; 19(9):868-873.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|